Acadia Healthcare (NASDAQ:ACHC) Stock Price Target Raised at Guggenheim

Acadia Healthcare (NASDAQ:ACHC) had its target price upped by Guggenheim from $39.00 to $41.00 in a research report report published on Friday,Benzinga reports. They currently have a buy rating on the stock.

Several other equities analysts have also commented on the company. Raymond James Financial downgraded Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $39.00 target price on the stock. in a research report on Monday, September 28th. Barclays raised their price target on Acadia Healthcare from $32.00 to $35.00 and gave the stock an “equal weight” rating in a research note on Thursday. Leerink Partners lifted their price target on Acadia Healthcare from $30.00 to $33.00 and gave the company a “market perform” rating in a report on Wednesday, September 23rd. TD Cowen upped their price objective on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Finally, UBS Group increased their price objective on shares of Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 9th. Eight research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $32.54.

Acadia Healthcare Trading Up 6.4%

ACHC traded up $2.21 during trading on Friday, hitting $37.00. The company’s stock had a trading volume of 4,533,735 shares, compared to its average volume of 1,614,038. Acadia Healthcare has a twelve month low of $11.43 and a twelve month high of $39.38. The stock has a market cap of $3.44 billion, a PE ratio of -2.97, a PEG ratio of 9.54 and a beta of 0.64. The firm’s 50 day moving average price is $29.40 and its 200-day moving average price is $26.14. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.14. The business had revenue of $895.31 million for the quarter, compared to analysts’ expectations of $877.76 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%. The business’s revenue was up 5.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.72 earnings per share. On average, analysts expect that Acadia Healthcare will post 1.59 earnings per share for the current year.

Institutional Trading of Acadia Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the company. BlackRock Inc. acquired a new position in Acadia Healthcare in the second quarter valued at $441,685,000. Jefferies Financial Group Inc. purchased a new stake in Acadia Healthcare during the second quarter valued at about $106,458,000. Deutsche Bank AG acquired a new stake in Acadia Healthcare during the second quarter worth about $49,746,000. First Trust Advisors LP increased its stake in Acadia Healthcare by 73.0% during the first quarter. First Trust Advisors LP now owns 1,689,442 shares of the company’s stock worth $39,516,000 after acquiring an additional 712,852 shares during the last quarter. Finally, Braidwell LP increased its stake in Acadia Healthcare by 76.7% during the second quarter. Braidwell LP now owns 1,141,477 shares of the company’s stock worth $33,708,000 after acquiring an additional 495,577 shares during the last quarter.

Trending Headlines about Acadia Healthcare

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Acadia reported third-quarter EPS of $0.60, ahead of the $0.46 consensus, and revenue of $895.3 million, above estimates and up 5.1% year over year. The company also raised its full-year guidance, with its outlook described as slightly above expectations. Article
• Positive Sentiment: Guggenheim raised its target to $41 and kept a Buy rating; RBC lifted its target from $31 to $41 and maintained Outperform. These revisions reinforce optimism about further gains. Article Article
• Neutral Sentiment: Cantor Fitzgerald raised its target to $39 but retained a Neutral rating, signaling a more cautious view than the bullish analyst calls. Analyst rating
• Negative Sentiment: Quarterly EPS was below the $0.72 reported a year earlier. Barclays raised its target to $35 but kept an Equal Weight rating; that target is below the cited current share price, suggesting limited upside in its view. Analyst rating

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.